logo
Select company
Select metric
$ -4.46MEarning Before Interest & Taxes (EBIT)
VS
Market
35
Sector
73
Industry
88
History
57
$ 34.69Close
$ 18.76 - $ 39.72 52-Week Range
Ticker Information

Ticker

XOMA

Company Name

XOMA ROYALTY CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XOMA ROYALTY CORP - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XOMA - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -4.46M
3/31/2025$ 2.5M
12/31/2024$ -11.11M
9/30/2024$ -20.32M
6/30/2024$ -10.71M
3/31/2024$ -35.49M
12/31/2023$ -40.26M
9/30/2023$ -26.71M
6/30/2023$ -25.38M
3/31/2023$ -24.65M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XOMA ROYALTY CORP's latest trailing twelve months (TTM) EBIT stands at $ -13.15M.
  • Over the past 5 years, XOMA ROYALTY CORP's average EBIT has been $ -5.17M.
  • The median EBIT for XOMA ROYALTY CORP during this period was $ -7.58M
  • XOMA ROYALTY CORP reached its highest EBIT over the past 5 years at $ 21.15M.
  • The lowest EBIT recorded by XOMA ROYALTY CORP in the same timeframe $ -40.26M

XOMA ROYALTY CORP's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
SCPH : SCPHARMACEUTICALS INC $ -85.59MLXRX : LEXICON PHARMACEUTICALS INC $ -108.05MGOSS : GOSSAMER BIO INC $ -131.32MCDXS : CODEXIS INC $ -54.12MEDIT : EDITAS MEDICINE INC $ -242.16MFENC : FENNEC PHARMACEUTICALS INC $ -8.49MAQST : AQUESTIVE THERAPEUTICS INC $ -48.08MFHTX : FOGHORN THERAPEUTICS INC $ -75.39MSPRO : SPERO THERAPEUTICS INC $ -53.6MCELU : CELULARITY INC $ -65.72M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

XOMA - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -40.26M

Minimum

Dec 31, 2023

$ 21.15M

Maximum

Mar 31, 2022

$ -5.17M

Average

$ -7.58M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M